Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 100 #1
TickerTTWO [NASD]
CompanyTake-Two Interactive Software Inc.
CountryUSA
IndustryMultimedia & Graphics Software
Market Cap2.30BEPS (ttm)-2.15
P/E-EPS this Y988.90%
Forward P/E21.16EPS next Y-26.61%
PEG-EPS past 5Y31.20%
P/S2.35EPS next 5Y8.50%
P/B2.70EPS Q/Q-92.20%
Dividend-Sales Q/Q-71.50%
Insider Own1.10%Inst Own-
Insider Trans-43.66%Inst Trans-5.03%
Short Float17.65%EarningsMay 18/a
Analyst Recom2.30Target Price33.08
Avg Volume2.05M52W Range18.79 - 30.80
May-22-15 04:52PMVideo Game Stock Roundup: EA, IGT and Activision in Focus - Analyst Blog
May-22-15 06:07AMTAKE TWO INTERACTIVE SOFTWARE INC Files SEC form 10-K, Annual Report
May-21-15 09:58AMJim Cramer on Take-Two Interactive (TTWO): Should Trade on Par With EA, Activision Blizzard at TheStreet
May-21-15 06:00AMJim Cramer's Top Takeaways: WhiteWave, Hain, Take-Two, Fiat Chrysler, Salesforce.com at TheStreet
May-20-15 08:02PMJim Cramer's 'Mad Money' Recap: Stick With the Peerless Winners at TheStreet
May-20-15 07:06PMCramer Remix: Absolute worst thing in the market at CNBC
May-20-15 03:19PM6 stocks to watch at MarketWatch
May-20-15 02:17PMMobile vs. Console Gaming: Who Is Winning? at The Wall Street Journal
May-20-15 10:10AMCompany News for May 20, 2015 - Corporate Summary
May-20-15 09:32AMTake-Two Interactive Software (TTWO) Rises, Stock Adds 18.2% - Tale of the Tape
Take-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment for consumers worldwide. The company offers its products under the Rockstar Games and 2K labels. It develops and publishes action/adventure products under the Grand Theft Auto, Max Payne, Midnight Club, and Red Dead names through developing sequels, offering downloadable episodes and content, and releasing titles for smartphones and tablets. The company also develops brands in other genres, including the L.A. Noire, Bully, and Manhunt franchises. In addition, it publishes various entertainment properties across platforms and a range of genres, including shooter, action, role-playing, strategy, sports, and family/casual entertainment under the BioShock, Mafia, Sid Meier's Civilization, and XCOM series, as well as Borderlands franchise; and various sports simulation titles, including its flagship NBA 2K series, a basketball video game and the WWE 2K series. Further, the company develops and publishes titles for the casual and family-friendly games comprising Carnival Games and Let's Cheer, as well as has an agreement with Nickelodeon to publish video games. Its portfolio of brands also comprise Evolve, Rockstar Games Presents Table Tennis, Sid Meier's Pirates!, Spec Ops, and Spin. The company's products are designed for console gaming systems, such as Sony's PlayStation 3 and PlayStation 4, Microsoft's Xbox 360 and Xbox One, and Nintendo's Wii and Wii U; handheld gaming systems, including Nintendo's DS and Sony's PlayStation Portable; and personal computers comprising smartphones and tablets. It delivers its products through physical retail, digital download, online platforms, and cloud streaming services. Take-Two Interactive Software, Inc. was founded in 1993 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slatoff KarlPresidentMay 21Sale27.6419,948551,3630May 22 09:10 PM
Slatoff KarlPresidentMay 21Sale27.64152,3864,211,9491,699,205May 22 09:10 PM
ZELNICK STRAUSSChairman and CEOMay 21Sale27.64152,3864,211,9491,699,205May 22 09:11 PM
Slatoff KarlPresidentMay 20Sale27.5219,948548,9070May 22 09:10 PM
Slatoff KarlPresidentMay 20Sale27.72152,3864,223,8201,976,268May 22 09:10 PM
TickerRPTP [NASD]
CompanyRaptor Pharmaceuticals Corp.
CountryUSA
IndustryBiotechnology
Market Cap952.08MEPS (ttm)-0.87
P/E-EPS this Y30.80%
Forward P/E-EPS next Y28.90%
PEG-EPS past 5Y0.50%
P/S12.24EPS next 5Y-
P/B24.14EPS Q/Q-16.70%
Dividend-Sales Q/Q69.40%
Insider Own1.00%Inst Own55.10%
Insider Trans-30.35%Inst Trans5.00%
Short Float22.21%EarningsMay 07/a
Analyst Recom2.30Target Price18.60
Avg Volume1.46M52W Range7.82 - 12.23
May-20-15 04:03PMRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
May-18-15 05:07PMRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other
May-15-15 01:04PMRAPTOR PHARMACEUTICAL CORP Financials
May-09-15 08:09PM10-Q for Raptor Pharmaceutical Corp. at Company Spotlight
May-07-15 07:19PMRaptor Pharmaceutical reports 1Q loss
May-07-15 04:13PMRAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
May-07-15 04:04PMRaptor Pharmaceutical Reports First Quarter 2015 Financial Results and Provides Corporate Update GlobeNewswire
May-07-15 07:07AMQ1 2015 Raptor Pharmaceutical Corp Earnings Release - After Market Close
Raptor Pharmaceutical Corp., a biopharmaceutical company, focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. The company offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults, as well as in six years and older children in the United States, in the 28 member states of the European Union, Norway, Liechtenstein, and Iceland. Its clinical development programs include RP103 that is used as a treatment for Huntington's disease; RP103 as a treatment for non-alcoholic fatty liver disease in children; and RP103 as a treatment for mitochondrial disorders, including Leigh syndrome. The company's other clinical-stage product candidates comprise Convivia, an oral formulation of 4-methylpyrazole for the treatment of acetaldehyde toxicity resulting from aldehyde dehydrogenase deficiency. Its preclinical product candidates include cysteamine dioxygenase and HepTide for the treatment of hepatocellular carcinoma and other cancers susceptible to induced lysosomal storage. Raptor Pharmaceuticals Corp. has a collaboration agreement with DaVita Clinical Research to screen blood samples from the United States patients with end-stage renal disease to identify patients with unrecognized late-onset nephropathic cystinosis. The company was founded in 2005 and is headquartered in Novato, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Daley Thomas EChief Business OfficerMay 20Sale12.0010,000120,00064,719May 22 09:01 PM
FRANKLIN RICHARD LDirectorMay 04Option Exercise2.9710,00029,70011,674May 05 07:15 PM
FRANKLIN RICHARD LDirectorMay 04Sale9.6110,00096,0751,674May 05 07:15 PM
FRANKLIN RICHARD LDirectorApr 02Option Exercise2.9710,00029,70011,674Apr 06 09:42 PM
FRANKLIN RICHARD LDirectorApr 02Sale10.3710,000103,6671,674Apr 06 09:42 PM
TickerICPT [NASD]
CompanyIntercept Pharmaceuticals, Inc.
CountryUSA
IndustryBiotechnology
Market Cap6.29BEPS (ttm)-3.58
P/E-EPS this Y-262.50%
Forward P/E-EPS next Y0.10%
PEG-EPS past 5Y0.00%
P/S2247.62EPS next 5Y18.01%
P/B14.64EPS Q/Q85.10%
Dividend-Sales Q/Q250.00%
Insider Own2.30%Inst Own68.20%
Insider Trans-59.11%Inst Trans5.45%
Short Float15.00%EarningsMay 11/b
Analyst Recom1.80Target Price414.56
Avg Volume649.03K52W Range128.50 - 349.08
May-22-15 09:02PMWill This Drug Beat Gilead to Market in NASH? at Investopedia
May-21-15 02:19PMBiotech: Don't Bet Against Small Caps Just Yet at Barrons.com
May-21-15 12:22PMCoverage initiated on Intercept Pharma by Barclays
May-21-15 10:27AMTwo Picks Boosted by Intercept NASH Trial at Barrons.com
May-21-15 09:00AM4 SMID-Cap Biotechs Barclays Just Confessed It Loves
May-20-15 03:25PMIntercept Pharmaceuticals Reveals Phase III OCA Study Plan - Analyst Blog
May-20-15 08:45AMIntercept Pharmaceuticals (ICPT) in Focus: Stock Tanks 16.1% - Tale of the Tape
May-20-15 08:27AMIntercept Pharmaceuticals Downgraded
May-19-15 05:36PMStock Pops & Drops: GPRO, ICPT, RIG & RCL
May-19-15 05:27PMIntercept's NASH Trial Design Irks Investors at Investor's Business Daily
Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. It primarily develops obeticholic acid (OCA), a bile acid analog that completed Phase III clinical trial for the treatment of primary biliary cirrhosis; is in Phase III clinical trial for the treatment of nonalcoholic steatohepatitis; is in Phase 2 clinical trial for primary sclerosing cholangitis; and is in Phase I clinical trial for the treatment of biliary atresia. The company's product candidates in preclinical stage include INT-767, an orally administered dual FXR and TGR5 agonist for the treatment of fibrosis; and INT-777, an orally administered TGR5 agonist used in treating type 2 diabetes. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILLIAMS NICOLEDirectorMay 20Option Exercise9.829739,5571,935May 22 09:00 PM
WILLIAMS NICOLEDirectorMay 20Sale260.20973253,175962May 22 09:00 PM
AKKARAJU SRINIVASDirectorMay 19Option Exercise21.501,00021,5008,642May 22 09:00 PM
Shapiro DavidCMO and EVP - DevelopmentMay 15Option Exercise8.673,50030,33322,793May 19 09:01 PM
Shapiro DavidCMO and EVP - DevelopmentMay 15Sale306.904,2791,313,24418,514May 19 09:01 PM
TickerTWTR [NYSE]
CompanyTwitter, Inc.
CountryUSA
IndustryInternet Information Providers
Market Cap23.96BEPS (ttm)-0.98
P/E-EPS this Y71.80%
Forward P/E54.46EPS next Y97.65%
PEG-EPS past 5Y0.00%
P/S15.09EPS next 5Y69.13%
P/B6.35EPS Q/Q-8.70%
Dividend-Sales Q/Q74.00%
Insider Own1.30%Inst Own57.30%
Insider Trans-47.72%Inst Trans10.13%
Short Float4.11%EarningsApr 28/a
Analyst Recom2.50Target Price47.67
Avg Volume20.31M52W Range30.38 - 55.99
May-23-15 05:29AMIreland Backs Gay Marriage in Landslide Victory for Yes Camp at Bloomberg
May-23-15 05:29AMIreland Backs Gay Marriage in Landslide Victory
May-23-15 05:00AM'Fast Money' Recap -- Transportation Stocks in Slowdown, a Treading Dow, Technology in the News at TheStreet
May-22-15 03:41PMEarly Twitter Investor To Air Grievances at Fox Business
May-22-15 03:00PMTwitter Might Be the Most Important Customer Service Center You Have Entrepreneur
May-22-15 02:25PMTwitter opens technology center for San Francisco homeless at MarketWatch
May-22-15 01:17PMThe Tech Stocks That Unseated Apple Inc. (AAPL) in Daniel Bentons Portfolio: Twitter Inc (TWTR), Tesla Motors Inc (TSLA), Facebook Inc (FB) at Insider Monkey
May-22-15 12:06PMJim Cramer Says Own Ebay as a Way to Play Its Split with Paypal at TheStreet
May-22-15 11:39AMTwitters most candid investor is about to offer some critiques at MarketWatch
Twitter, Inc. operates as a global platform for public self-expression and conversation in real time. It offers various products and services for users, including Twitter that allows users to create, distribute, and discover content; and Vine and video, a mobile application that enables users to create and distribute short looping videos. The company also provides promoted products and services, such as promoted tweets, promoted accounts, and promoted trends that enable its advertisers to promote their brands, products, and services; and subscription access to its data feed for data partners. In addition, it offers a set of tools, public APIs, and embeddable widgets that developers can use to contribute their content to its platform; syndicate and distribute Twitter content across their properties; and enhance their Websites and applications with Twitter content. The company was founded in 2006 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams Evan ClarkDirectorMay 21Sale36.7311,160409,9312,854,522May 22 08:36 PM
Williams Evan ClarkDirectorMay 21Sale36.73174,8406,422,393504,278May 22 08:36 PM
Noto AnthonyChief Financial OfficerMay 20Buy36.743,000110,2261,383,557May 22 08:35 PM
Williams Evan ClarkDirectorMay 20Sale36.9311,160412,1572,865,682May 22 08:36 PM
Williams Evan ClarkDirectorMay 20Sale36.94174,8406,458,164506,138May 22 08:36 PM
TickerEGAN [NASD]
CompanyeGain Corporation
CountryUSA
IndustryBusiness Software & Services
Market Cap105.17MEPS (ttm)-0.40
P/E-EPS this Y-800.00%
Forward P/E-EPS next Y51.30%
PEG-EPS past 5Y-31.30%
P/S1.35EPS next 5Y-
P/B32.75EPS Q/Q-125.00%
Dividend-Sales Q/Q6.70%
Insider Own0.20%Inst Own30.20%
Insider Trans-15.16%Inst Trans5.54%
Short Float3.33%EarningsMay 06/b
Analyst Recom2.00Target Price6.85
Avg Volume67.94K52W Range2.82 - 7.14
May-20-15 01:04PMEGAIN CORP Financials
May-20-15 06:30AMNavy Federal Credit Union Selects eGain for Proactive Member Service Marketwired
May-10-15 08:11PM10-Q for eGain Corp. at Company Spotlight
May-08-15 04:20PMEGAIN CORP Files SEC form 10-Q, Quarterly Report
May-06-15 09:00AMeGain Issued Three Patents in Real-Time Collaboration Across Digital and Voice Marketwired
May-06-15 08:02AMEGAIN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
May-06-15 07:07AMQ3 2015 eGain Corp Earnings Release - Before Market Open
eGain Corporation provides cloud-based and on-site customer engagement software solutions. The company offers eGain 11 applications for businesses to engage, acquire, and serve customers through various engagement channels. Its eGain 11 suite includes eGain Mobile that enables business to offer its eGain-enabled engagement options to mobile users through phone and tablet apps; eGain Social to monitor social networks; and eGain Community for creating and managing online communities or forums, community knowledge harvesting, and single-sourced publishing. The company's eGain 11 suite also consists of eGain Offers, which helps businesses engage visitors on the company Website and Facebook fan pages; eGain Virtual Assistant for text and speech chat interactions; eGain Cobrowse, which enable phone and chat reps to show customers around the Website, help locate information, and hand-hold them during complex tasks; eGain Chat that enables Website visitors to conduct text and video chats with agents; eGain ClickToCall, which provide Website visitors to request a callback while browsing; and eGain SelfService that supports various self-service access options. In addition, its eGain 11 suite comprises eGain CaseManager, a case logging system; eGain Mail for processing inbound customer emails; eGain Knowledge, which empowers contact center agents with knowledge management; eGain SecureMessaging for secure and authenticated messaging between businesses and customers; and eGain Notify for managing and delivering automatic reminders, alerts, and updates at various stages of customer journey. Further, the company provides consulting, implementation, maintenance, support, and training services. It serves customers operating in the retail, telecommunications, financial services, insurance, outsourced services, technology, utilities, government, manufacturing, and consumer electronics industry sectors. The company was founded in 1997 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SMIT ERICChief Financial OfficerMay 22Option Exercise0.6417,50011,200168,197May 22 08:30 PM
SMIT ERICChief Financial OfficerMay 22Sale3.909,56037,331158,637May 22 08:30 PM
NARANG PROMODSenior Vice PresidentMay 19Option Exercise0.6490,00057,600264,105May 21 01:10 PM
SHOCKLEY BRETT ADirectorMay 15Option Exercise3.7450,000187,00050,000May 19 06:17 PM
SMIT ERICChief Financial OfficerMay 13Option Exercise0.645,0003,200150,697May 14 05:10 PM
TickerSNI [NYSE, S&P 500]
CompanyScripps Networks Interactive, Inc.
CountryUSA
IndustryBroadcasting - TV
Market Cap8.79BEPS (ttm)3.90
P/E17.54EPS this Y12.60%
Forward P/E14.00EPS next Y11.37%
PEG1.60EPS past 5Y18.20%
P/S3.28EPS next 5Y10.93%
P/B7.63EPS Q/Q8.00%
Dividend1.35%Sales Q/Q2.30%
Insider Own13.90%Inst Own84.30%
Insider Trans-19.54%Inst Trans-2.27%
Short Float17.39%EarningsMay 07/b
Analyst Recom2.80Target Price77.39
Avg Volume1.15M52W Range65.61 - 85.78
May-19-15 08:57AMTwo Weeks Remain to Enter the HGTV Smart Home 2015 Giveaway Business Wire
May-19-15 08:33AMScripps Networks Interactive Prices Debt Offering of $1.5 Billion of Senior Notes Business Wire
May-18-15 04:54PMSCRIPPS NETWORKS INTERACTIVE, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement
May-18-15 03:30PMSCRIPPS NETWORKS INTERACTIVE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matte
May-18-15 02:23PMScripps Networks Interactive, Inc. -- Moody's assigns Baa1 rating to Scripps Networks Interactive Inc.'s new bond offering; ratings under review for downgrade at Moody's
May-14-15 08:31AM3 Reasons Why Scripps Networks (SNI) Is a Great Growth Stock - Tale of the Tape
May-13-15 04:15PMArgus Recommends 4 'Growth Stocks'
May-13-15 04:03PMScripps Networks Interactive Declares Quarterly Dividend Business Wire
Scripps Networks Interactive, Inc. develops lifestyle-oriented content for linear and interactive video platforms in the United States, the United Kingdom and other European markets, the Middle East and Africa, the Asia-Pacific, and Latin America. The company delivers content that focuses on specifically defined topics of interest for audiences and advertisers. It operates national television networks, including Home and Garden Television (HGTV), Food Network, Travel Channel, DIY Network, Cooking Channel, and Great American Country; and Websites comprising HGTV.com, FoodNetwork.com, TravelChannel.com, DIYNetwork.com, CookingChanneltv.com, and GACTV.com that are associated with the aforementioned television brands and other Internet-based businesses serving home, food, and travel related categories. The company also licenses its content to third parties; and brands for consumer products, such as videos, books, kitchenware, and tools. Scripps Networks Interactive, Inc. is headquartered in Knoxville, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vasquez Virginia S.10% OwnerMay 22Sale68.60100,0006,859,73048,719May 22 08:11 PM
SAGANSKY JEFFREYDirectorMay 19Sale68.002,137145,32211,580May 19 02:17 PM
Peirce MaryDirectorMay 15Sale65.994,546300,00226,934May 15 02:12 PM
Scripps Jimmy R.10% OwnerMay 15Sale65.983,530232,920937,647May 15 04:08 PM
Brickner Rebecca Scripps10% OwnerMay 15Sale65.9910,734708,3350May 15 04:08 PM
TickerCRM [NYSE, S&P 500]
Companysalesforce.com, inc.
CountryUSA
IndustryApplication Software
Market Cap49.17BEPS (ttm)-0.42
P/E-EPS this Y-7.70%
Forward P/E81.98EPS next Y32.23%
PEG-EPS past 5Y-35.80%
P/S9.15EPS next 5Y27.14%
P/B12.02EPS Q/Q47.40%
Dividend-Sales Q/Q26.10%
Insider Own5.80%Inst Own91.30%
Insider Trans-4.93%Inst Trans-0.03%
Short Float3.97%EarningsMay 20/a
Analyst Recom2.00Target Price76.74
Avg Volume5.51M52W Range49.93 - 78.46
May-22-15Reiterated Needham Buy $80 → $85
May-22-15 08:19PMTech Today: More M&A Fever, Apple's TV Hitch, Chip Prospects at Barrons.com
May-22-15 07:23PMIBD Market Wrap - 05/26/15
May-22-15 06:00PMCramer shuts down this market's haters
May-22-15 05:24PMBiz Break: Salesforce wanted $70 billion from Microsoft, report says at San Jose Mercury News
May-22-15 05:19PMSALESFORCE COM INC Files SEC form 10-Q, Quarterly Report
May-22-15 04:07PMStocks Stall as Investors Clear Out For Long Weekend at TheStreet
May-22-15 04:00PMMarket hungry for dovish words?
May-22-15 03:29PMMicrosoft walked away from Saleforce deal over price at bizjournals.com
May-22-15 03:17PMMicrosoft and Salesforce Merge? So You're Saying There's a Chance at TheStreet
May-22-15 03:14PMMicrosoft tried to buy Salesforce for $55B, report says
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. The company offers enterprise cloud computing apps and platform services, including Sales Cloud for sales force automation, which enables companies to store data, access accurate customer and prospect information, track leads and progress, forecast opportunities, and collaborate around any sale on desktop and mobile devices; Service Cloud that enables companies to connect address customers service and support needs; and Marketing Cloud, which enables companies to map customer journeys to digital marketing interactions through email, mobile, social, Web, and connected products. It also provides Community Cloud, a platform to engage specific group of people with access to relevant information, apps, and experts; Analytics Cloud, an app and platform to deploy sales, service, marketing, and custom analytics apps using any data source; Salesforce1 Platform, a cloud platform to build apps that manage various business processes. In addition, the company provides professional services, including consulting, deployment, training, implementation, and integration services to facilitate the adoption of its cloud solutions. It sells and markets its services primarily through its direct sales force, as well as through global consulting firms, systems integrators, and regional partners. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChairman of the Board & CEOMay 22Option Exercise35.6312,500445,31337,675,000May 22 07:56 PM
Benioff MarcChairman of the Board & CEOMay 22Sale73.5812,500919,75637,662,500May 22 07:56 PM
Benioff MarcChairman of the Board & CEOMay 21Option Exercise35.6312,500445,31337,675,000May 22 07:56 PM
Benioff MarcChairman of the Board & CEOMay 21Sale73.3212,500916,53337,662,500May 22 07:56 PM
Benioff MarcChairman of the Board & CEOMay 20Option Exercise35.6312,500445,31337,675,000May 22 07:56 PM
TickerAMPH [NASD]
CompanyAmphastar Pharmaceuticals, Inc.
CountryUSA
IndustryDrug Manufacturers - Other
Market Cap661.86MEPS (ttm)-0.24
P/E-EPS this Y-196.30%
Forward P/E259.65EPS next Y-
PEG-EPS past 5Y5.80%
P/S3.14EPS next 5Y5.00%
P/B2.35EPS Q/Q-250.00%
Dividend2.03%Sales Q/Q1.80%
Insider Own2.70%Inst Own24.00%
Insider Trans-5.51%Inst Trans35.76%
Short Float1.79%EarningsMay 13/a
Analyst Recom3.00Target Price32.50
Avg Volume213.55K52W Range6.67 - 16.28
May-22-15 01:04PMAMPHASTAR PHARMACEUTICALS, INC. Financials
May-14-15 06:16AMAMPHASTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
May-13-15 05:00PMAmphastar Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
May-13-15 06:27AMAmphastar reports 1Q loss
May-13-15 06:05AMAMPHASTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen
May-13-15 06:00AMAmphastar Pharmaceuticals Reports Net Revenues of $56.9 Million for the First Quarter Ended March 31, 2015 GlobeNewswire
May-11-15 02:30PM4 Big-Volume Stocks to Trade for Breakouts at TheStreet
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable and inhalation products. It operates in two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company's product portfolio comprises Enoxaparin, a low molecular weight heparin that is used as an anticoagulant for prevention and treatment of deep vein thrombosis; Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients presumed with adrenocortical insufficiency; and Lidocaine jelly, a local anesthetic product used primarily for urological procedures. It also provides syringe products, which include critical care drugs, such as atropine, calcium chloride, dextrose, epinephrine, lidocaine, naloxone, and sodium bicarbonate for emergency use in hospital settings; phytonadione injection for newborn use; lidocaine topical solution for use as a local anesthetic; morphine; epinephrine in vial form; and lorazepam injection. In addition, the company develops Primatene Mist HFA, an over-the-counter epinephrine inhalation product candidate that is intended to be used for the temporary relief of mild symptoms of intermittent asthma; Amphadase, a bovine-sourced hyaluronidase injection; and active pharmaceutical ingredients, such as recombinant human insulin and porcine insulin. Its products are used in hospital or urgent care clinical settings, and primarily contracted and distributed through group purchasing organizations and drug wholesalers. The company was established in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRINS RICHARD KDirectorMay 22Option Exercise10.771,94220,91537,993May 22 07:51 PM
PRINS RICHARD KDirectorMay 22Sale14.761,94228,65436,051May 22 07:51 PM
PRINS RICHARD KDirectorMay 21Option Exercise11.6811,901139,00447,952May 22 07:51 PM
PRINS RICHARD KDirectorMay 21Sale14.7613,565200,17936,051May 22 07:51 PM
PRINS RICHARD KDirectorMay 20Option Exercise11.6813,945162,87849,996May 22 07:51 PM
TickerMCK [NYSE, S&P 500]
CompanyMcKesson Corporation
CountryUSA
IndustryDrugs Wholesale
Market Cap55.71BEPS (ttm)7.54
P/E31.91EPS this Y24.00%
Forward P/E16.47EPS next Y16.07%
PEG1.91EPS past 5Y10.30%
P/S0.31EPS next 5Y16.70%
P/B6.98EPS Q/Q-1.20%
Dividend0.40%Sales Q/Q14.30%
Insider Own0.29%Inst Own86.60%
Insider Trans-38.47%Inst Trans-0.49%
Short Float0.50%EarningsMay 12/a
Analyst Recom1.80Target Price256.35
Avg Volume972.04K52W Range177.89 - 243.61
May-22-15 01:04PMMCKESSON CORP Financials
May-21-15 06:15PMCramer: You must own drug company or biotech
May-19-15 04:10PMMcKesson Corporation to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Business Wire
May-18-15 12:27PMFour Stocks to Avoid If Rates Rise at Barrons.com
May-18-15 09:35AMMorgan Stanley's 4 Health Care and Pharma Stocks to Buy for the Long Term at TheStreet
May-15-15 02:07PMDan Loeb's 13F Shows Alibaba Swapped For Yum! Brands
May-15-15 01:02PMSuccessful Health IT Deals Are Obamacare Agnostic at Forbes
McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment, and health and beauty care products. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers; and practice management, technology, clinical support, and business solutions to oncology and other specialty practices operating in the community setting. In addition, this segment offers medical-surgical supply distribution, equipment, logistics, and other services to healthcare providers through a network of distribution centers in the United States; sells financial, operational, and clinical solutions for pharmacies; and provides consulting, outsourcing, and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions; and connectivity, outsourcing, and other services, such as remote hosting and managed services to healthcare organizations. This segment also offers InterQual clinical criteria solution, claims payment solutions, and network performance tools. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies, and payers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Figueredo JorgeEVP, Human ResourcesMay 22Option Exercise87.2412,2501,068,69012,250May 22 07:49 PM
Figueredo JorgeEVP, Human ResourcesMay 22Sale239.9112,2502,938,8510May 22 07:49 PM
Figueredo JorgeEVP, Human ResourcesMay 21Option Exercise118.418,5251,009,4458,525May 22 07:49 PM
Figueredo JorgeEVP, Human ResourcesMay 21Sale240.418,5252,049,4950May 22 07:49 PM
Figueredo JorgeEVP, Human ResourcesMay 15Option Exercise118.418,5251,009,4458,525May 18 05:32 PM
TickerSFLY [NASD]
CompanyShutterfly, Inc.
CountryUSA
IndustryPersonal Services
Market Cap1.78BEPS (ttm)-0.50
P/E-EPS this Y-183.30%
Forward P/E134.57EPS next Y206.10%
PEG-EPS past 5Y-23.80%
P/S1.89EPS next 5Y16.50%
P/B2.55EPS Q/Q-33.70%
Dividend-Sales Q/Q16.70%
Insider Own2.40%Inst Own-
Insider Trans-22.03%Inst Trans-3.88%
Short Float10.06%EarningsApr 29/a
Analyst Recom2.20Target Price51.08
Avg Volume454.61K52W Range38.95 - 54.79
May-22-15 12:02PM12:02 pm Shutterfly releases statement to shareholders; asking for a universal proxy card, and shareholder votes in favor of its Board nominees at it's upcoming annual meeting
May-22-15 12:00PMShutterfly Proposes Universal Proxy Card for 2015 Annual Meeting Business Wire
May-22-15 09:56AM6 Internet Stories Cantor Fitzgerald Analysts Are Following Benzinga
May-22-15 08:17AMPro reshuffles Internet picks. Here's why...
May-18-15 09:08AMMarathon Partners Comments on Shutterfly's Recently Revealed and Troubling 2015 CEO Compensation Plan
May-18-15 09:03AMMarathon Partners Comments on Shutterfly's Recently Revealed and Troubling 2015 CEO Compensation Plan PR Newswire
May-15-15 01:04PMSHUTTERFLY INC Financials
May-14-15 11:27AMShutterfly Open To Transactions Offering 'Compelling Value'
May-13-15 08:03PMShutterfly: Would Consider 'Compelling' Transactions at The Wall Street Journal
Shutterfly, Inc. manufactures and retails in digital personalized products and services in the United States. It offers a range of personalized photo-based products and services for consumers to upload, edit, enhance, organize, find, share, create, print, and preserve their memories. The company also produces and sells photo books, greeting and stationery cards, and personalized calendars, as well as other photo-based merchandise, including calendars, mugs, canvas prints, mouse pads, magnets, puzzles, iPhone cases, and desktop plaques; and photo prints. In addition, it develops an iPhone application that allows users to access their photos from iPhones, or their Facebook or Instagram accounts, and create customized products and gifts from their mobile devices, as well as a photo book making software; and provides cloud-based services for protecting, organizing, storing, and sharing photos and videos. Further, the company develops technologies for photo ranking, analysis, and organization, which allows customers to organize and select the photos; offers Groovebook, a mobile photo book app subscription service that sends customers a keepsake book of their mobile photos each month; and provides BorrowLenses, an online marketplace for photographic and video equipment rentals. The company offers its products and services under the Shutterfly, Tiny Prints, Wedding Paper Divas, ThisLife, MyPublisher, and BorrowLenses brands. Shutterfly, Inc. was founded in 1999 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KELLER ERIC JDirectorMay 22Sale47.866,424307,48022,855May 22 07:42 PM
BORIS JOHNSVP, Chief Marketing OfficerMay 18Sale47.2410,416492,04272,263May 19 07:36 PM
MARINEAU PHILIP ADirectorMay 07Option Exercise16.512,22036,65255,958May 08 08:03 PM
MARINEAU PHILIP ADirectorMay 07Sale44.992,22099,87853,738May 08 08:03 PM
MARINEAU PHILIP ADirectorMay 01Option Exercise16.514,44073,30458,178May 04 08:09 PM
1 2 3 4 5 6 7 8 9 10 next